Glucose control,
redefined
Powered by pA1c®HI — a clinically validated postbiotic for metabolic regulation. Genbioma® translates microbiome complexity into industrial-ready solutions that deliver measurable results.
Powered by pA1c®HI — a clinically validated postbiotic for metabolic regulation. Genbioma® translates microbiome complexity into industrial-ready solutions that deliver measurable results.
Glucose dysregulation is a central factor in many metabolic disorders. Most existing approaches focus on managing glucose levels rather than addressing the underlying biological mechanisms driving the imbalance.
This gap between symptom control and biological regulation is where new solutions must operate.
pA1c®HI is a clinically validated postbiotic ingredient designed to regulate glucose metabolism through targeted microbiome interaction.
Developed for real-world application, it combines clinical validation with industrial performance, offering a stable and scalable alternative to traditional approaches.
Supported by human clinical studies showing impact on key metabolic makers.
Stable under pasteurization and UHT conditions.
Long shelf life and stable without cold chain.
Neutral sensory profile and easy to formulate.
Unlike probiotics, pA1c®HI does not rely on live bacteria. It is based on bioactive compounds that provide greater stability, consistency and reproducibility.
This approach brings microbiome science closer to industrial reality.
pA1c®HI is a functional ingredient developed for foods, beverages and supplements.
Its compatibility with industrial processes enables easy incorporation into existing formulations, supporting product innovation without adding complexity.
The Reglubetic® range offers a complete, convenient solution to support metabolic health.
Available as easy-to-take capsules or sugar-free gummies, Reglubetic®HI is powered by our exclusive heat-inactivated postbiotic, pA1c®HI, to sustain glucose regulation.
